|« Previous month||Next month »|
29-Feb-2016 - Sanofi will tap Japanese academics' personalised medicine knowhow under a new collaboration with the University of Tokyo's translational research initiative (TR).
26-Feb-2016 - Bial says BIA 10-2474 met safety and tolerability requirements for human trials, but the firm cannot rule the drug out as the cause of lesions in dogs in a preclinical study....
26-Feb-2016 - GSK has invested €12m ($14m) into a site in Ireland to develop and manufacture ingredients for its future portolio.
25-Feb-2016 - Cobra Biologics and the UK Centre for Process Innovation (CPI) will develop a manufacturing system for the viruses used to deliver gene therapies.
25-Feb-2016 - The US Senate has voted to support the confirmation of Robert Califf as new US Food and Drug Administration (FDA) commissioner.
25-Feb-2016 - Shott Trinova has confirmed its intention to offer API production and process development at the UK laboratory it acquired Covance.
25-Feb-2016 - Researchers at Ohio State University are hiding cancer drugs inside a “molecular Trojan horse” in order to successfully infiltrate drug-resistant cells.
25-Feb-2016 - Novartis has confirmed its offices in South Korea were visited by local authorities earlier this week.
24-Feb-2016 - The US FDA has given approval to Zydus Cadila to market an antibiotic made from an Indian facility hit with a Warning Letter in December.
24-Feb-2016 - International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement in which ICIG will acquire all shares in Sandoz Industrial Products GmbH.
24-Feb-2016 - Recipharm will pay SEK640m ($75m) for Italian antibiotic filling specialist Mitim in a deal expected to complete later today.
24-Feb-2016 - A technology collaboration with Thiologics could increase the efficiency and yield of albumin-conjugated drugs, says Novozymes spin-out Albumedix.
24-Feb-2016 - Indian drug and API importers can apply for licenses online through a new service launched by the Central Drugs Standards Control Organisation (CDSCO).
24-Feb-2016 - A European project aimed at improving formulations for children is seeking industry help to develop a database on excipient safety.
23-Feb-2016 - Sanofi is poised to terminate its Auvi-Q marketing deal says PDL Biopharma, citing manufacturing issues last year which led to a complete recall of the epinephrine injection product.
23-Feb-2016 - Grünenthal has selected Patheon as its preferred development partner for its anti-abuse formulation platform INTAC, based on Hot Melt Extrusion (HME) technology.
23-Feb-2016 - Japanese researchers have developed a peptide vaccine with the potential to protect the brain when administered prior to a stroke, according to a study presented at the American Stroke Association’s...
23-Feb-2016 - ARC Trinova plans to add API process development capcity at the animal testing lab it bought from Covance.
22-Feb-2016 - Bacterial resistance to ciproflaxin is spreading according to the European CDC which wants the drug industry to invest in development of alternatives to the "last resort" antibiotic.
22-Feb-2016 - Teva has aggressively defended its market share for its blockbuster Copaxone says Momenta, six months after marketing partner Sandoz launched the first generic version in the US.
22-Feb-2016 - Research examining how API particle characteristics impact drug stability will help safeguard Denmark’s $12bn (DKK80bn) a year drug manufacturing industry say scientists.
22-Feb-2016 - There are concerns that pharma companies are not fully prepared to meet the new requirements on risk-assessment for excipients, even though the deadline is just a few weeks away.
22-Feb-2016 - ScinoPharm Taiwan announced its unaudited financial results for fiscal year 2015, and with it, plans to expand its contract businesses through strategic acquisitions.
18-Feb-2016 - Qualicaps has swapped a manufacturing technology customer for dominance of Brazil's fast growing pharmaceutical capsule market through a recent acquisition.
18-Feb-2016 - Capsugel has come on leaps-and-bounds since it was spun-out from Pfizer, the firm says as it inks a deal with Pulmatrix to develop inhaled therapeutics.
|« Previous month||Next month »|